Sunday, 31 May 2020

South Korea's Celltrion says COVID-19 drug shows drop in viral load in animal testing

South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)